Clinical Trial

Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The aim of the research is the laboratory assessment of the content as well as the regenerative and anti-inflammatory potential of autologous exosomes (EXO) from platelet-rich plasma (PRP), as well as their comparison with other autologous products used in intra-articular injections, namely platelet-rich plasma and platelet-rich fibrin (PRF). The material for the research will be obtained from patients of the Temporomandibular Joint Dysfunction Clinic at the University Dental Center in Wrocław with chronic pain of the temporomandibular joints (TMJ) and/or masticatory muscles and/or chronic disturbances in temporomandibular joint mobility, as well as from healthy individuals. In the subsequent stages, the biological material will be analyzed under laboratory conditions to compare the composition and biological properties of PRP, PRF and EXO.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-30.
Trial Details
NCT Number NCT07511959
Lead Sponsor Wroclaw Medical University
Conditions Temporomandibular Disorders (TMD), Muscle Pain, TMJ Pain
Enrollment 68 participants
Start Date 2026-05-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-13